File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Developing the ethical framework of end-stage kidney disease care: from practice to policy

TitleDeveloping the ethical framework of end-stage kidney disease care: from practice to policy
Authors
Keywordsdialysis
end-stage kidney disease
ESKD
ethics
Issue Date2020
PublisherElsevier Inc. The Journal's web site is located at http://www.sciencedirect.com/science/journal/00852538
Citation
Kidney International Supplements, 2020, v. 10 n. 1, p. e72-e77 How to Cite?
AbstractEthical issues relating to end-stage kidney disease (ESKD) care are increasingly being discussed by clinicians and ethicists but are still infrequently considered at a policy level or in the education and training of health care professionals. In most lower-income countries, access to kidney replacement therapies such as dialysis is not universal, leading to overt or implicit rationing of resources and potential exclusion from care of those who are unable to sustain out-of-pocket payments. These circumstances create significant inequities in access to ESKD care within and between countries and impose emotional and moral burdens on patients, families, and health care workers involved in decision-making and provision of care. End-of-life decision-making in the context of ESKD care in all countries may also create ethical dilemmas for policy makers, professionals, patients, and their families. This review outlines several ethical implications of the complex challenges that arise in the management of ESKD care around the world. We argue that more work is required to develop the ethics of ESKD care, so as to provide ethical guidance in decision-making and education and training for professionals that will support ethical practice in delivery of ESKD care. We briefly review steps that may be required to accomplish this goal, discussing potential barriers and strategies for success.
Persistent Identifierhttp://hdl.handle.net/10722/289764
ISSN
2023 Impact Factor: 19.3
2023 SCImago Journal Rankings: 3.126
PubMed Central ID
ISI Accession Number ID

 

DC FieldValueLanguage
dc.contributor.authorLuyckx, VA-
dc.contributor.authorMartin, DE-
dc.contributor.authorMoosa, MR-
dc.contributor.authorBello, AK-
dc.contributor.authorBellorin-Font, E-
dc.contributor.authorChan, TM-
dc.contributor.authorClaure-Del Granado, R-
dc.contributor.authorDouthat, W-
dc.contributor.authorEiam-Ong, S-
dc.contributor.authorEke, FU-
dc.contributor.authorGoh, BL-
dc.contributor.authorJha, V-
dc.contributor.authorKendal, E-
dc.contributor.authorLiew, A-
dc.contributor.authorMengistu, YT-
dc.contributor.authorMuller, E-
dc.contributor.authorOkpechi, IG-
dc.contributor.authorRondeau, E-
dc.contributor.authorSahay, M-
dc.contributor.authorTrask, M-
dc.contributor.authorVachharajani, T-
dc.date.accessioned2020-10-22T08:17:08Z-
dc.date.available2020-10-22T08:17:08Z-
dc.date.issued2020-
dc.identifier.citationKidney International Supplements, 2020, v. 10 n. 1, p. e72-e77-
dc.identifier.issn2157-1724-
dc.identifier.urihttp://hdl.handle.net/10722/289764-
dc.description.abstractEthical issues relating to end-stage kidney disease (ESKD) care are increasingly being discussed by clinicians and ethicists but are still infrequently considered at a policy level or in the education and training of health care professionals. In most lower-income countries, access to kidney replacement therapies such as dialysis is not universal, leading to overt or implicit rationing of resources and potential exclusion from care of those who are unable to sustain out-of-pocket payments. These circumstances create significant inequities in access to ESKD care within and between countries and impose emotional and moral burdens on patients, families, and health care workers involved in decision-making and provision of care. End-of-life decision-making in the context of ESKD care in all countries may also create ethical dilemmas for policy makers, professionals, patients, and their families. This review outlines several ethical implications of the complex challenges that arise in the management of ESKD care around the world. We argue that more work is required to develop the ethics of ESKD care, so as to provide ethical guidance in decision-making and education and training for professionals that will support ethical practice in delivery of ESKD care. We briefly review steps that may be required to accomplish this goal, discussing potential barriers and strategies for success.-
dc.languageeng-
dc.publisherElsevier Inc. The Journal's web site is located at http://www.sciencedirect.com/science/journal/00852538-
dc.relation.ispartofKidney International Supplements-
dc.subjectdialysis-
dc.subjectend-stage kidney disease-
dc.subjectESKD-
dc.subjectethics-
dc.titleDeveloping the ethical framework of end-stage kidney disease care: from practice to policy-
dc.typeArticle-
dc.identifier.emailChan, TM: dtmchan@hkucc.hku.hk-
dc.identifier.authorityChan, TM=rp00394-
dc.description.naturelink_to_OA_fulltext-
dc.identifier.doi10.1016/j.kisu.2019.11.003-
dc.identifier.pmid32149011-
dc.identifier.pmcidPMC7031685-
dc.identifier.scopuseid_2-s2.0-85079209822-
dc.identifier.hkuros315892-
dc.identifier.volume10-
dc.identifier.issue1-
dc.identifier.spagee72-
dc.identifier.epagee77-
dc.identifier.isiWOS:000530722300009-
dc.publisher.placeUnited States-
dc.identifier.issnl2157-1716-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats